Skip to content

Samplix raised €25 million (about $27.88 million) in a seed round led by WLanholding GmbH, announced Oct. 28.

Facts

Company
Samplix
Amount
€25 million (about $27.88 million)
Currency
EUR
Stage
Seed
Announced
Oct 28, 2026
Instrument
Convertible note
FX rate
1 EUR = 1.115 USD on Oct 27, 2026

Investors

Use of funds

To strengthen balance sheet and broaden commercial adoption of the Xdrop platform, particularly in antibody discovery.

As stated by the company.

Sources

  1. 1.Danish BioTech Samplix secures €25 million in first close of financing round to scale antibody discovery — EU-Startups, Oct 28, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 28, 2026